National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 8) (PB 74 of 2019) (Cth)

PB 74 of 2019

National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 8)

National Health Act 1953

___________________________________________________________________________

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated        29 August 2019

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

_________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 8).

(2)This Instrument may also be cited as PB 74 of 2019.

1. Commencement

This Instrument commences on 1 September 2019.

1. Amendment of National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

1. Schedule 1, omit entry for Alendronic acid with colecalciferol and calcium

1. Schedule 1, entry for Mirtazapine

omit:

Tablet 15 mg (orally disintegrating)	Oral	Avanza SolTab	30	3.85	8.27
Tablet 30 mg (orally  disintegrating)	Oral	Avanza SolTab	30	5.13	9.55
Tablet 45 mg (orally  disintegrating)	Oral	Avanza SolTab	30	7.72	12.14